LakeShore Biopharma Co. L... (LSB)

2.51

0.01 (0.36%)

At close: Mar 28, 2025, 3:47 PM

2.60

3.68%

After-hours: Mar 28, 2025, 07:55 PM EDT

LakeShore Biopharma Co. Ltd Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21
Net Income	-433.46M	-145.48M	-545.73K	-191.83M
Depreciation & Amortization	42.19M	36.69M	31.15M	27.91M
Stock-Based Compensation	9.79M	3.51M	7.76M	76.76M
Other Working Capital	39.23M	-6.45M	-64.05K	-44.29K
Other Non-Cash Items	153.78M	4.42M	-3.45K	2.23M
Deferred Income Tax	-21.73M	1.13M	4.94M	17.45M
Change in Working Capital	-45.79M	-92.75M	-64.05K	-186.68M
Operating Cash Flow	-295.23M	-182.47M	-613.23K	-246.61M
Capital Expenditures	-44.25M	-57.05M	-298.93M	-104.88M
Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-200M	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	-44.25M	-56.98M	-200M	-104.24M
Debt Repayment	-78.93M	100.88M	364.56M	8.26M
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	216.57M	-163.06M	729.41M
Financial Cash Flow	205.26M	317.45M	201.5M	739.26M
Net Cash Flow	-123.82M	99.3M	-389.57M	388.41M
Free Cash Flow	-339.48M	-239.52M	-299.55M	-351.49M